IP Library Granted Patent US 10,696,839
Granted Patent B2
US 10,696,839 · App. 16/125,077 · Granted Jun 30, 2020

Curable composition for cured in place pipes

Inventors: Richard E. Nawracaj (Burr Ridge, IL); Gabriel Urbieta (Chicago, IL); Radames Dejesus (Forest Park, IL)
Assignee: PipeFusion CIPP Corporation
C08L63/00C08J3/075C08K5/357C08J2363/00C08L2203/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,696,839
App. No.
16/125,077
Granted
Jun 30, 2020
Kind
B2
Abstract

Disclosed is a curable composition with enhanced curing time at ambient temperatures, the curable composition including (a) a resin, e.g., 4,4′-isopropylidenediphenol-epichlorohydrin copolymer and (b) one or more curing agents, wherein a ratio of a weight percentage of the resin to a weight percentage of the curing agent or curing agents is from about 12:1 to about 15:1. Also disclosed is a method of curing a cured-in-place liner, wherein the cured-in-place liner contains the above curable composition.

Claims (28)

1. A curable composition comprising,

(a) a resin comprising 4,4′-isopropylidenediphenol-epichlorohydrin copolymer;

(b) one or more curing agents of Formula (I):

wherein A is —CH 2 —;

R is a C 1 -C 3 alkylene chain, wherein the hydroxyl group may be attached to any of the carbon atoms of the alkylene chain;

R 1 and R 2 are each independently hydrogen; and

X is a carboxylate anion,

wherein a ratio of a weight percentage of the resin to a weight percentage of the curing agent or curing agents of formula (I) is from about 12:1 to about 15:1;

(c) a diluent which is a monofunctional epoxide selected from C 12 -C 14 glycidyl ethers;

(d) a filler;

(e) a rheology modifier; and

(f) a defoamer;

wherein said curable composition has a gel time of about 12 to about 24 hours when cured in a cured-in-place liner at 21° C.

2. The curable composition of claim 1 , wherein X is the carboxylate anion of a carboxylic acid comprising from 1 to about 40 carbon atoms.

3. The curable composition of claim 1 , wherein the ratio of the weight percentage of the resin to the weight percentage of the curing agent or curing agents of formula (I) is from about 12:1 to about 14:1.

4. The curable composition of claim 3 , wherein the ratio of the weight percentage of the resin to the weight percentage of the curing agent or curing agents of formula (I) is about 12:1.

5. The curable composition of claim 1 , wherein the composition requires a temperature of at least about 85° C. to begin a curing process.

6. The curable composition of claim 1 , wherein the composition begins a curing process at a temperature of about 60° C. to about 85° C.

7. The curable composition of claim 1 , wherein the composition has a gel time of about 14 hours to about 22 hours at a temperature of 21° C.

8. The curable composition of claim 7 , wherein the composition has a gel time of about 16 hours to about 20 hours at a temperature of 21° C.

9. The curable composition of claim 1 , wherein the curing agent is a carboxylate of an amine selected from N-hydroxypropylpiperidine, N-hydroxymethylpiperidine, N-hydroxyethylpiperidine, and combinations thereof.

10. The curable composition of claim 9 , wherein the carboxylate is a carboxylate anion of an acid selected from tall oil fatty acid (TOFA), oleic acid, acetic acid, propanoic acid, 2-ethylhexanoic acid, decanoic acid, and hexanoic acid, succinic acid, glutaric acid, adipic acid, and pimelic acid.

11. The curable composition of claim 9 , wherein a ratio of a weight percentage of the resin to a weight percentage of the curing agent or curing agents of formula (I) is from 12:1 to 15:1.

12. The curable composition of claim 9 , wherein a ratio of a weight percentage of the resin to a weight percentage of the curing agent or curing agents of formula (I) is from 12:1 to 13:1.

13. The curable composition of claim 9 , wherein the curing agent is a carboxylate of an amine selected from N-hydroxymethylpiperidine, N-hydroxyethylpiperidine, and combinations thereof.

14. The curable composition of claim 13 , wherein the curing agent is a carboxylate of N-hydroxyethylpiperidine.

15. The curable composition of claim 14 , wherein a ratio of a weight percentage of the resin to a weight percentage of the curing agent or curing agents of formula (I) is from 12:1 to 13:1.

16. The curable composition of claim 13 , wherein a ratio of a weight percentage of the resin to a weight percentage of the curing agent or curing agents of formula (I) is from 12:1 to 13:1.

Assignments (3)
CHANGE OF NAME Recorded Apr 29, 2020
From: CORVIXX POLYMERS CIPP CORPORATION
To: PIPEFUSION CIPP CORPORATION
Reel/Frame 052531/0864 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 16, 2019
From: INTELLECTUAL PROPERTY RESOURCES, INC.
To: CORVIXX POLYMERS CIPP CORPORATION
Reel/Frame 049765/0538 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2019
From: NAWRACAJ, RICHARD E.; URBIETA, GABRIEL; DEJESUS, RADAMES
To: INTELLECTUAL PROPERTY RESOURCES, INC.
Reel/Frame 049423/0642 →
Continuity (1)
Related Publication 20200079953A1 · Mar 12, 2020